1. "Department of Medicine"
Formats
  1. Journal Article (19347)
  2. Meeting Abstract (15822)
  3. Review (1102)
  4. Book Section (924)
  5. Editorial (580)
  6. Research Letter (301)
  7. Conference Paper (299)
  8. Guidelines (285)
  9. Correspondence (226)
  10. Miscellaneous (87)
  11. Book Whole (61)
Groups
  1. Department of Medicine (39034)
  2. Solid Tumor Oncology Division (22035)
  3. Hematologic Malignancies, Division of (13003)
  4. Center for Hematologic Malignancies (10841)
  5. GSK Faculty (10529)
  6. Survivorship Research (9202)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Sergio Giralt (1050)
  4. Miguel-Angel Perales (913)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (642)
  2. 2024 (2141)
  3. 2023 (2451)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2560)

More Years

Publications
  1. Journal of Clinical Oncology (6050)
  2. Blood (3572)
  3. Annals of Oncology (1395)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (890)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6364)
  2. Elsevier Inc. (4610)
  3. American Society of Hematology (3843)
  4. American Association for Cancer Research (2879)
  5. Oxford University Press (2271)
  6. Nature Publishing Group (2080)

More Publishers

Results (39034)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • New treatment options in advanced squamous cell lung cancer
    Review

    Paik, P. K.; Pillai, R. N.; Lathan, C. S.; Velasco, S. A.; Papadimitrakopoulou, V.
    American Society of Clinical Oncology Educational Book (2019)

    Fulltext@MSK | Save
  • Establishing a mutually respectful environment in the workplace: A toolbox for performance excellence
    Review

    Duma, N.; Maingi, S.; Tap, W. D.; Weekes, C. D.; Thomas, C. R. Jr
    American Society of Clinical Oncology Educational Book (2019)

    Fulltext@MSK | Save
  • Value-added decisions in oncology
    Review

    Tannock, I.; Presley, C. J.; Saltz, L. B.
    American Society of Clinical Oncology Educational Book (2019)

    Fulltext@MSK | Save
  • Improving health outcomes in pancreatic cancer using animated pancreas patient (APP) visual formats of learning: A National Pancreas Foundation (NPF) patient education initiative
    Meeting Abstract

    Munigala, S.; O'Reilly, E. M.; Alsante, M.; Holt, J. M.; Ko, A. H.; Gelrud, A.
    Pancreas (2019)

    Fulltext@MSK | Save
  • Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients with a germline BRCA mutation and metastatic pancreatic vancer (mPC): Phase III POLO trial
    Meeting Abstract

    Golan, T.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; more...
    Pancreas (2019)

    Fulltext@MSK | Save
  • APACT: Phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) versus gemcitabine (G) for surgically resected pancreatic adenocarcinoma
    Meeting Abstract

    Ko, A.; Reni, M.; Riess, H.; Pelzer, U.; O'Reilly, E. M.; Winter, J.; Oh, D. Y.; Li, C. P.; Tortora, G.; Chang, H. M.; more...
    Pancreas (2019)

    Fulltext@MSK | Save
  • Brentuximab vedotin (BV) versus physician's choice (PC) of methotrexate or bexarotene in adult patients with previously treated CD30-positive cutaneous T-cell lymphoma (CTCL; mycosis fungoides [MF] or primary cutaneous anaplastic large cell lymphoma [pcALCL]): Final time to next therapy (TTNT) results from the phase 3 ALCANZA study
    Meeting Abstract

    Scarisbrick, J.; Horwitz, S. M.; Prince, H. M.; Whittaker, S.; Duvic, M.; Kim, Y. H.; Quaglino, P.; Zinzani, P. L.; Bechter, O.; Eradat, H.; more...
    European Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Outcomes and prognostic factors in African American/Black patients with mycosis fungoides and Sézary syndrome
    Meeting Abstract

    Geller, S.; Lebowitz, E.; Pulitzer, M. P.; Horwitz, S. M.; Moskowitz, A. J.; Dusza, S.; Myskowski, P. L.
    European Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (MBM; CheckMate 204)
    Meeting Abstract

    Tawbi, H.; Forsyth, P.; Hodi, F. S.; Lao, C.; Moschos, S.; Hamid, O.; Atkins, M. B.; Lewis, K.; Thomas, R. P.; Glaspy, J. A.; more...
    British Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (aNSCLC): CheckMate 227 - part 2 final analysis
    Meeting Abstract

    Paz-Ares, L.; Ciuleanu, T. E.; Yu, X.; Salman, P.; Pluzanski, A.; Nagrial, A.; Havel, L.; Kowalyszyn, R.; Audigier-Valette, C.; Wu, Y. L.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save